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Nuclear factor-kB binding to the HIV-1 LTR in kidney: Impli- the ages of 20 to 64 [1]. HIV-1 has been shown to infect
cations for HIV-associated nephropathy. renal cells and likely plays a direct role in the pathogenesis
Background. We have recently shown that renal epithelium of HIVAN [2–4]. The targets of HIV-1 infection in theis infected by HIV-1 and supports HIV-1 transcription in sero-
kidney are cells of epithelial origin, including tubular epi-positive patients with renal disease. To investigate the regula-
thelia, podocytes, and parietal epithelial cells in the glo-tion of HIV-1 gene expression in kidney, an HIV-1 transgenic
mouse model was used to analyze the host transcriptional pro- merulus. These are the same cells that exhibit pathogenic
teins that bind the 59 long-terminal repeat (LTR). changes in both human and animal models of HIVAN
Methods. Viral gene expression was assessed in transgenic [3, 5–9]. In renal cells, fundamental aspects of the viralmouse tissue using Northern blotting and mRNA in situ hybrid-
life cycle that are dependent on host cell proteins, suchization. The transcription factors involved in LTR binding were
as viral gene expression, have not been studied.determined using electrophoretic mobility shift assays. Cyto-
plasmic and nuclear extracts were prepared from tissues with The regulation of HIV-1 gene expression has been
varied levels of transgene expression. The binding of transcrip- studied extensively in cells of lymphoid origin, the typical
tion factors to specific LTR fragments was determined using host cells for HIV-1 replication. Transcriptional regula-DNA competition experiments and supershifts with transcrip-
tion is achieved using the available host transcriptionaltion factor-specific antibodies.
proteins that interact with the viral promoter and enhancerResults. Tissue-specific expression of the transgene was vari-
able, with viral gene expression in the kidney at an intermediate contained within the 59 long-terminal repeat (LTR) [10].
level as compared with other tissues. Overall, the level of trans- Following integration into the host genome, the viral
gene expression directly correlated with abundance of nuclear protein Tat can up-regulate transcription through inter-factor-kB (NF-kB) in the nuclear extracts. High expressing tis-
actions with the host transcriptional machinery and thesue, however, had a constitutively active form of NF-kB. In
viral transactivation response (TAR) element. The hostcontrast, the kidney contained an inducible NF-kB, which bound
the LTR in combination with Sp1, suggesting a requirement transcriptional proteins, NF-kB and Sp1, have been shown
for an activating event in renal HIV-1 expression of the LTR. to be critical in regulating HIV-1 LTR transcription in
Conclusions. These studies indicate that the regulation of lymphocytes, with specific protein–protein interactionsthe HIV-1 LTR in the kidney is similar to lymphoid tissues,
between nuclear factor-kB (NF-kB) and Sp1 necessaryand may explain, in part, why the HIV-1 life cycle is supported
for viral gene expression [11, 12]. On an integrated andin kidney.
chromatin-associated provirus, NF-kB and Sp1 binding
to the LTR is required for assembly of the basal tran-
scriptional complex as well as responsiveness to Tat [13].Human immunodeficiency virus-associated nephropa-
Expression of the LTR has also been studied in atypi-thy (HIVAN) is currently the third leading cause of end-
cal host cells for HIV-1, specifically microglial and astro-stage renal disease in African American males between
cytes of the central nervous system (CNS). In these cell
types, LTR transcription is not regulated by NF-kB and
1 Present address: University of Pennsylvania, 904 Stellar Chance Labo- Sp1. Viral isolates from the brains of patients with AIDS
ratory, 422 Curie Blvd., Philadelphia, PA 19104, USA. dementia contain LTR mutations [14], which permit ex-
pression through transcriptional proteins that are not re-Key words: viral gene expression, chronic renal disease, LTR, end-
stage renal disease, epithelial cells, 59 long terminal repeat. quired for expression in lymphoid cells, including C/EBP,
NF-IL6, and ATF/CREB [15–17]. In addition, in vitroReceived for publication April 12, 2000
and transgenic mouse studies have shown that lympho-and in revised form January 11, 2001
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The present study was designed to determine the
mechanism of LTR regulation in the kidney. It is un-
known whether LTR activity in the kidney uses the pro-
totypical lymphotropic expression pattern involving
NF-kB and Sp1 or is similar to CNS infections in which
alternative transcriptional mechanisms have evolved. To
address this issue, we have used an HIV-1 transgenic
mouse model to characterize the host transcriptional fac-
Fig. 1. Diagram of HIV-1 59 long terminal repeat (LTR) and DNAtors that interact with the LTR in kidney. NF-kB and fragments used in electrophoretic mobility shift assay (EMSA). The
Sp1 bound the LTR in transcriptionally active cells. The shaded boxes indicate consensus-binding sites for known transcription
factors. The region spanning 2160 to 180 contains the sites previouslylevel of nuclear NF-kB correlated directly with levels of
shown to be important in regulating LTR activity in a variety of celltransgene expression. In a tissue with a high level of types. The size and location of DNA fragments used in the EMSA are
expression, constitutively active NF-kB was present. In indicated.
the kidney, both Sp1 and NF-kB were required for com-
plex formation on the LTR. The NF-kB found in renal
cells was an inducible form bound to IkB in the cyto-
Roy, Gosselin, and Guerin [26]. Briefly, 2 to 4 g of freshplasm. These observations are similar to the transcrip-
tissue were minced with a razor blade, and single-celltional mechanism described in lymphocytes.
suspensions achieved using a Dounce homogenizer in
4 mL of buffer A containing the following protease inhib-
METHODS itors: 5 mg/mL TLCK and 40 mg/mL TPCK, 10 mg/mL
Transgenic mice aprotinin, 5 mg/mL leupeptin, 70 mg/mL phenylmethyl-
sulfonyl fluoride (PMSF), and 0.5 mmol/L EGTA (allThe transgenic mouse line TgN(pNL43d14)26Lom used
from Roche Molecular Diagnostics, Montclair, NJ, USA).in these studies has been reported previously [19, 20]. This
Following filtration through cheesecloth, cells were col-line contains ten copies of the HIV-1 proviral DNA
lected by centrifugation at 1000 3 g for 10 minutes andpNL4-3d1443, which was generated by deleting the gag
resuspended in 4 mL of buffer A plus 0.5% Nonidet P-40.and pol genes from the infectious molecular clone NL4-3.
The cells were homogenized with the tight-fitting pestleTranscription of the transgene is controlled by the native
and centrifuged as before. The supernatant from this stepLTR. We have previously shown the homozygous and
was used for the preparation of the cytoplasmic extractsheterozygous mice develop multiorgan pathology, includ-
as previously described [27]. The pellet was resuspendeding a progressive renal disease clinically and pathologically
in three pellet volumes of buffer A plus 350 mmol/L KClsimilar to HIVAN. HIV-1 expression in the kidney [5, 21]
and one tenth of the pellet volume of 4 mol/L KCl. Thisas well as the skin [22] is etiologic in pathogenesis.
was centrifuged for ten minutes at 48C in a microcentri-
RNA expression analysis fuge followed by centrifugation at 180,000 3 g. The su-
pernatant was dialyzed against buffer D containing 0.1Northern blots were performed using total cellular
mmol/L ZnCl2 and frozen in aliquots for storage atRNA isolated [23] from various organs of 30- to 40-day-
2808C. Total protein content was estimated by a modi-old heterozygous animals. Ten micrograms of RNA were
fied Lowry assay (Bio-Rad).resolved on a 0.8% agarose/formaldehyde gel and trans-
Electrophoretic mobility shift assay (EMSA) was per-ferred to nylon membranes. Hybridization conditions
formed as described [25]. The DNA fragments used forand the nef probe used to detect all viral mRNAs were
these studies included the following: a 22 bp double-as previously described [24]. Blots were analyzed using
stranded oligonucleotide containing one NF-kB site, aa phosphorimager (Molecular Analyst; Bio-Rad, Her-
90 bp fragment containing the tandem repeat of thecules, CA, USA).
NF-kB sites and three adjacent Sp1 sites as they appearmRNA in situ hybridizations were performed as de-
in the LTR, and a 240 bp fragment spanning 180 toscribed using a digoxigenin riboprobe capable of de-
2160 (Fig. 1). The NF-kB sites in the HIV-1 LTR aretecting all viral transcripts [21]. Kidneys were obtained
of sequence identity to wild-type Ig-kB sites (“ctgGGGfrom 30- to 40-day-old transgenic mice and prepared for
ACTTTCCgct”). All oligos and DNA fragments usedin situ hybridizations as described [4].
in the EMSA contained NF-kB sites of this sequence.
Nuclear extracts and electrophoretic mobility The DNA fragments were 59 end labeled with g32P-ATP
shift assay and polynucleotide kinase. Binding reactions consisted
of the labeled DNA (10,000 cpm), nuclear extracts (1 toNuclear and cytoplasmic extracts were prepared from
10 mg), along with a nonspecific competitor (5 mg polydI-cell suspensions isolated from whole tissue as described
[25] with a modification for tissue disruption adapted from dC) and were resolved on 6 or 8% nondenaturing poly-
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acrylamide gels using 0.5 3 TBE buffer. Control extracts
were Ntera-2 cells transfected with plasmids containing
NFKB1 or NFKB1 and RelA and were provided by
Dr. Keith Brown (NIAID/NIH, Bethesda, MD, USA).
These extracts were prepared as previously described
[28]. As additional controls, double-stranded DNA frag-
ments for a consensus Sp1 site and a mutant NF-kB site
were purchased (ProMega Biotech, Madison, WI, USA)
and used in cold competition studies at 100-fold molar
excess to verify the identity of shift complexes. The mu-
tant NF-kB site contained a three nucleotide substitution
(“ctgTCTACTTTCCgct”) in the p50 half site, which has
no NF-kB binding activity.
Antibodies used for the supershifts and Western blot-
Fig. 2. Analysis of HIV-1 gene expression in transgenic mice. (A)ting were rabbit polyclonals obtained from Santa Cruz Northern analysis of HIV-1 gene expression in transgenic mice. Abbre-
Biotech (Santa Cruz, CA, USA) at concentrations of 10 viations are: G, gut; K, kidney. (B) mRNA in situ hybridization for
HIV-1 in transgenic mouse kidney. The cell types that express theor 100 mg/mL. These included for the p50 subunits NFKB1
transgene include tubular epithelia, podocytes in the glomerulus, and(sc-7178) and NFKB2 (sc-298 and sc-848) and for the parietal epithelial cells lining Bowman’s capsule. Because of the greater
p65 subunits RelA (sc-109 and sc-372), RelB (sc-226), sensitivity of the in situ hybridization technique, the level of expression
in the kidney appears higher than the Northern blot.and c-Rel (sc-272 and sc-70).
Western blotting
Nuclear extracts were resolved on 6% denaturing
blot likely represented the level of transgene expressionpolyacrylamide gels as previously described [29] and
in tubular epithelia.were electroblotted to polyvinylidine difluoride (PVDF)
This restricted tissue expression of viral mRNA sug-membranes. All primary antibodies (same as used in
gests that the host transcriptional proteins required forEMSA) were used at a 1:500 dilution with incubation at
LTR activity were differentially expressed in the variousroom temperature for 12 hours, followed by a goat anti-
cell types. To identify the host transcription factors thatrabbit IgG antibody conjugate with horseradish peroxi-
bound the LTR, EMSAs were performed on nucleardase and color development with diaminobenzidine.
extracts isolated from representative tissues (kidney and
gut). Similar to the Northern blot, the bulk of the kidney
RESULTS extracts would be derived from tubular epithelia since
the kidney mass is over 90% tubular cells.We have previously characterized the tissue-specific
The transcription factors that bound the LTR DNAexpression of the transgene in this line of transgenic
fragments were confirmed using subunit-specific anti-mice [24]. By Northern analysis, the level of transgene
bodies for NF-kB and Sp1 in the EMSA. The interactionexpression was tissue specific. Expression in the kidney
of the antibody with the transcription factors would shiftas well as thymus, lymph node, and spleen was low as
the bands to higher apparent molecular weights (super-compared with other tissues, such as the gut, muscle,
shifts). The specificity of the antibodies as well as migra-and skin, which expressed the transgene at significantly
tion positions of specific NF-kB complexes was confirmedhigher levels (Fig. 2A). The kidney expressed all three
using control extracts isolated from cells transfected withpopulations of spliced viral mRNAs as determined by
individual NF-kB genes (Methods section). Figure 3A,reverse transcription-polymerase chain reaction of
lanes 1 and 2, shows the shift positions of p(50)2 homodi-mRNA splice junctions and is not defective in Rev activ-
mers (NFKB1) and p50/p65 heterodimers (NFKB1/ity [24]. In the kidney, the cell types that express the
RelA), as well as their supershift positions (Fig. 3A,transgene were of epithelial origin, including tubular epi-
lanes 4 through 6) when interacting with subunit-specificthelial cells as well as epithelial cells in the glomerulus,
antibodies. The kidney extracts (Fig. 3A, lanes 6 throughthe podocytes, and parietal cells of Bowman’s capsule
12) contained both p(50)2 homodimers and p50/p65 het-(Fig. 2B). We have recently shown that tubular epithelial
erodimers. The specificity of the interaction was con-cells from all nephron segments express the transgene,
firmed by competition using 100-fold molar excess ofand there appear to be very similar levels of expression
the DNA fragment that was not radioactively labeledin the different epithelial cell types (abstract; Ross et
(“cold”). The p50 supershifts (lane 11) confirmed theal, J Am Soc Nephrol 11:550A, 2000). Since glomeruli
presence of p50 in both homodimers and heterodimers.constitute a significantly smaller proportion of the bulk
of the kidney, the viral mRNA detected in the Northern The p65 supershift, although not complete in this experi-
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Fig. 3. Analysis of nuclear extracts by EMSA.
All experiments used a radioactively labeled
22 bp DNA fragment containing one consen-
sus NF-kB binding site. (A) Determination of
migration positions of NF-kB complexes and
supershifts composed of p(50)2 homodimers and
p50/p65 heterodimers. Lanes 1 through 5 are
EMSA with control nuclear extracts (Methods
section). Lane 1, shift position of p50 homodi-
mers. Lane 2, shift position of p50/p65 hetero-
dimers. Lane 3, supershift of p50 homodimers
with an antibody specific for p50 (NFKB1).
Lane 4, supershift of p50/p65 heterodimers
with an antibody specific for p50 (NFKB1).
Lane 5, supershift of p50/p65 heterodimers
with an antibody specific for p65 (RelA). Note
that in lanes 4 and 5, weak supershift bands
are observed with the complete loss of normal
shift bands. Frequently the antibody binding
disrupts the DNA-protein complex resulting
in a loss of the shift band; however, this still
indicates antibody recognition. A lower mo-
lecular weight shift band was observed in some
extracts, which represents a nonspecific inter-
action (asterisk). Lanes 6 through 12 are EMSA performed with kidney nuclear extracts. Lane 6, 7, and 8 are a dose response of 2, 4, and 8 mg
of nuclear extract, respectively. Lanes 9 and 10, cold competition using an unlabeled NF-kB site and Sp1 site, respectively, demonstrating the
specificity of the protein interactions to the NF-kB site. Lanes 11 and 12, supershifts with antibodies specific for p50 (NFKB1) and p65 (RelA),
respectively. Note that the supershift for p65 was incomplete at this antibody concentration. (B) Control cold competitions and supershifts for
identification of specific and nonspecific complexes. In all EMSA, there appeared a lower molecular weight band that was nonspecific (asterisk),
which was verified by competition with a mutated NF-kB site. Lane 1, shift complex. Lanes 2, 3, and 4 are cold competitions with an NF-kB site,
a mutated NF-kB site, and an Sp1 site, respectively. Lanes 5, 6, and 7 are supershifts with p50, p65, and Sp1 antibodies, respectively. The specific
NF-kB complexes were not competed with the mutated NF-kB sites; in addition, nonspecific bands did not supershift with any of the antibodies.
(C) Identification of NF-kB subunits present in kidney extracts. In this experiment, antibody concentrations were tenfold higher than those used
in A and B, and complexes were resolved on 8% polyacrylamide gels so that shift positions could be better resolved. Complete supershifts were
observed with p50 and p65 antibodies, with no reactivity with antibodies to other subunits. One of the polyclonal p65 antibodies (“p65”) has cross-
reactivity with p50, resulting in a shift of both complexes.
ment due to insufficient antibody, showed binding with which has overlap with the 59 half site of the consensus
NF-kB site (“GGGACTTTCC”). Additional publishedthe p50/p65 heterodimer (lane 12), which can also be
observed by a reduction of the p50/p65 band as compared studies have shown that RBP-jk does not have binding
activity to the NF-kB site found in the HIV-1 LTR, andwith lane 10. In some supershifts, the interaction of the
antibody with the protein complex can interfere with thus, these observations indicate the nonspecific band
was not RBP-jk [30–32].DNA–protein interaction, which results in a loss or re-
duction of the shift complex. To determine which NF-kB proteins were present in
shift complexes, supershifts were performed using anti-As typical with EMSAs with NF-kB, there were non-
specific bands observed in all extracts (Fig. 3 A, B, aster- bodies specific to all known NF-kB family members (Fig.
3C). These studies used a tenfold higher concentrationisk), which migrated at different positions depending on
the cell sources of the extracts. These nonspecific bands of antibody than those shown in Figure 3 A and B to
ensure that the amount of antibody was not limiting. Inwere identified by performing a competition with both
unlabeled (“cold”) mutant NF-kB binding site and a na- this study, the only supershifts observed were with anti-
bodies to p50 (NFKB1) and p65 (RelA), and in each case,tive NF-kB site in excess of the labeled fragment. In these
competitions, all complexes were abolished when com- the antibodies completely supershifted the complexes.
This would indicate that the only participants in thepeted with a native NF-kB site (Fig. 3B, lane 2). How-
ever, only the nonspecific bands were abolished with the NF-kB complex from kidney extracts were p50 and p65.
Electrophoretic mobility shift assays using extracts iso-mutated NF-kB site (Fig. 3B, lane 3), indicating that these
complexes were not representing NF-kB binding. These lated from a highly expressing tissue (gut) and the kid-
ney, which expressed at a low level, were compared fornonspecific bands also did not supershift (Fig. 3B, lanes 5
through 7) with any of the NF-kB antibodies, also confirm- the presence of binding activity on LTR fragments. Ini-
tial EMSAs were performed on a 240 bp fragment span-ing that they did not contain NF-kB proteins. The identity
of this nonspecific band is not known. A recently described ning 2160 to 180 (Fig. 1), which encompassed all of
the previously described binding sites critical for LTRtranscriptional repressor protein, RBP-jk [30], has been
shown to bind the consensus sequence “CGTGGGAA,” activity, including two NF-kB sites, three Sp1 sites, and
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Fig. 4. Identification of transcription factors binding the LTR in various tissues using EMSA. (A) EMSA using the 90 bp LTR fragment with
extracts prepared from a high expressing tissue (gut) and a low expressing tissue (kidney). Unbound DNA is indicated by the arrow. There was
no difference in the shift complexes between nontransgenic (“C”) and transgenic mice (“Tg”). (B) EMSA using the 90 bp LTR fragment with
extracts prepared from gut. (C) EMSA using the 90 bp LTR fragment with extracts prepared from kidney. The free DNA band as shown in A
has been deleted, and only the shifted complexes are shown. The first lane in each panel is the shift complex, and remaining lanes are cold
competitions or supershifts with the indicated DNA fragments or antibodies.
the TATA box. Resolution of shift differences in the for LTR expression, the absence of NF-kB binding likely
would be the cause of low expression of the transgeneEMSA using large DNA fragments, however, was small
because of the size of the DNA itself. Thus, a smaller in kidney. NF-kB, however, is a ubiquitous transcription
factor, and it would be unlikely to have a cell type that didDNA fragment (90 bp) was used that spanned the NF-kB
and Sp1 sites (Fig. 1). The shift patterns on EMSA using not contain NF-kB. To confirm the presence of NF-kB in
the extracts, EMSAs were repeated using a 22 bp DNAthe 240 bp fragment were qualitatively similar to those
obtained with the 90 bp fragment, as determined by fragment containing a single NF-kB consensus site (Fig.
1). These EMSAs were not electrophoresed under condi-cold competition displacement experiments. As shown
in Figure 4A, the shift for the kidney had high molecular tions that would resolve p(50)2 homodimers from p50/
p65 heterodimers. NF-kB complexes were observed inweight complexes, which were significantly different than
the high expressing tissue (gut). Also, the transcription all tissues, and the abundance of the complexes corre-
lated with the level of expression (Fig. 5A). The highfactors isolated from the same organs from normal or
transgenic mice did not interact differently with the LTR expressing tissue had the most abundant NF-kB com-
plexes, with significantly less in the kidney. This nuclearfragments. Thus, the nuclear proteins interacting at the
LTR were not modified by viral gene products, but re- abundance of NF-kB was also determined using Western
blots of the nuclear extracts (Fig. 5B). The amounts offlected tissue-specific differences in the host transcription
factors. p50 (NFKB1) and p65 (RelA) detected in the Western
blots confirmed the relative abundance of nuclear NF-kBTo identify the proteins present in the shift complexes,
competitions with unlabeled DNA and antibody su- as detected in the EMSAs. In the gut, there was qualita-
tively more p50 than p65. This has been reported inpershifts were performed. The high expressing tissue
complex (gut) appeared to bind NF-kB, and complex several other experimental systems and is due to over-
production of p50 to ensure sequestration of all transacti-formation was dependent on NF-kB binding (Fig. 4B).
The LTR binding complex from kidney tissue was depen- vating p65 in complexes that can be regulated by IkB
[33]. In the kidney, no p65 was detected. Since p65 wasdent on Sp1 binding, although some competition was
observed with NF-kB (Fig. 4C). The results of these detected in the EMSA, however (Fig. 3), the level of
nuclear p65 appeared to be below the detection limitsstudies indicated that the high level of expression corre-
sponded to abundant NF-kB binding activity with no by Western blot with this antiserum.
The regulation of NF-kB is through the trapping ofdetectable binding of Sp1 (Fig. 4B). The lower level
of expression appeared to correspond with Sp1 binding the complex in the cytoplasm by IkB. In this form, DNA
binding activity is not present. To assess the cytoplasmicactivity predominantly (Fig. 4C).
Since NF-kB has previously been shown to be critical pool of NF-kB, we examined cytoplasmic extracts by
Bruggeman et al: NF-jB in HIVAN 2179
Fig. 5. Abundance of NF-kB in tissue extracts by EMSA and Western Fig. 6. Identification of constitutive NF-kB activity in the high express-
ing tissue. EMSAs were performed using the 22 bp DNA fragmentblotting. (A) EMSAs were performed using the 22 bp DNA fragment
containing one NF-kB consensus site with extracts from gut (lanes 1 containing one NF-kB site with nuclear and cytoplasmic extracts isolated
from the gut (G) and kidney (K). (A) Detection of NF-kB bindingthrough 3) and kidney (lanes 4 through 6). The first lane in each panel
(lanes 1 and 4) is the shift complex. The lower molecular weight bands activity in nuclear extracts. (B) Cytoplasmic extracts containing NF-kB
are typically bound with IkB and cannot interact with DNA. In the(asterisk) are nonspecific. Lanes 2 and 5 are cold competition with an
unlabeled NF-kB site. Lanes 3 and 6 are cold competition with an gut, a cytoplasmic form of NF-kB that bound the DNA fragment was
observed, indicating that it was not associated with IkB and was constitu-unlabeled mutant NF-kB site that cannot bind NF-kB. Note that the
nonspecific band (asterisk) was eliminated with this competition. (B) tively active. (C) Treatment of cytoplasmic extracts with a detergent
(deoxycholate) disruptions IkB interaction with NF-kB and allowsWestern blots on nuclear extracts using an antibody to p50 (NFKB1)
and p65 (RelA). The level of NF-kB in the EMSA was similar to that NF-kB to bind DNA. DNA binding activity in the cytoplasmic extracts
was restored in the kidney with a shift pattern similar to that observedobserved in the Western blot. Abbreviations are: G, gut; K, kidney.
The level of p50 appeared higher than p65 in the Western. This has in the nuclear extracts (A).
been reported in previously and is due to production of excess p50 to
ensure sequestration of all transactivating p65 in complexes that are
regulated by IkB.
binding activity, since recent reports have shown RBP-jk
is found only in the nucleus and is unaffected by most
protein disrupting agents, including deoxycholate [31].
EMSA (Fig. 6). With removal of IkB using detergents, Thus, this would indicate that the renal cells contained
DNA binding by cytoplasmic NF-kB can be detected. an inactive cytoplasmic pool of NF-kB that may be ac-
Cytoplasmic extracts not treated with detergent were tivated by any number of extracellular or intracellular
tested in the EMSA from the different tissues. Interest- stimuli.
ingly, NF-kB binding was detected in the cytoplasm from
the high expressing tissue, indicating the gut contains a
DISCUSSIONconstitutively active form of NF-kB (Fig. 6B). There was
no detectable NF-kB binding in the kidney cytoplasmic One of the major issues in HIVAN has been whether
extracts. Treatment of the kidney cytoplasmic extracts HIV-1 infects renal parenchymal cells. In our recent
(Fig. 6C) with detergent revealed the presence of NF-kB studies and previous work by others, HIV-1 does appear
(Fig. 6A). In these studies, the nonspecific band (as de- to infect renal epithelial cells [2–4, 7]. HIV-1 is not exclu-
scribed in Fig. 3) was also observed in cytoplasmic ex- sively lymphotropic and has been shown to infect a vari-
tracts treated with deoxycholate. This could represent a ety of cell types, including cells of the CNS, colon, and
form of NF-kB or possibly a proteolytic breakdown prod- cervix [34–36]. Defining viral tropism, in addition to viral
entry, must include provisions for all aspects of the viraluct of NF-kB. It would not be consistent with RBP-jk
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